Memorial Sloan Kettering Cancer Center shared a post on LinkedIn:
“Congratulations to Dr. Charles Sawyers, an investigator at Memorial Sloan Kettering Cancer Center (MSK), on receiving the 13th annual Harrington Prize for Innovation in Medicine.
Dr. Sawyers, who is Chair of Human Oncology and Pathogenesis Program at MSK and a Howard Hughes Medical Institute (HHMI) Investigator, was jointly awarded the prize with Dr. Arul Chinnaiyan, an investigator at the University of Michigan and the HHMI.
The award recognizes their transformative discoveries that defined the molecular drivers of prostate cancer and pioneered precision therapies that have reshaped the diagnosis and treatment of prostate cancer worldwide.
Together, Drs. Sawyers and Chinnaiyan have developed the contemporary framework for diagnosis and treatment of advanced prostate cancer and a basis for next generation therapies. The Harrington Prize for Innovation in Medicine recognizes their impact on improving outcomes in this deadly disease.
Dr. Sawyers also holds the Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis at MSK.
Other articles about MSK on OncoDaily.